Relmada Therapeutics, Inc

2222 Ponce de Leon Blvd Fl 3
Miami, FL 33134

Relmada Therapeutics, Inc. is a Miami-based biopharmaceutical company primarily focused on developing innovative therapies for major depressive disorders and other conditions. Following the discontinuation of its Phase 3 studies of REL-1017, the company has shifted its strategy towards exploring strategic product acquisitions while advancing its product pipeline, including NDV-01 and sepranolone.

With a commitment to maximizing shareholder value, Relmada is actively prioritizing resource allocation and expanding its portfolio through potential product acquisitions. The company recently appointed urology expert Dr. Raj S. Pruthi as Chief Medical Officer for urology, signaling its strategic focus on advancing life-changing therapies in the healthcare landscape.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesFloridaMiamiRelmada Therapeutics, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.